Fig. 4. Pathway alterations in early-onset prostate cancer.
Frequency of an alteration in select genes or pathways related to prostate cancer for (A) all patients, (B) primary disease, or (C) metastatic disease. FDR-corrected two-sided Fisher’s exact test used in all cases to compare early and typical groups: ns not significant; *p < 0.05; **p < 0.01. Gene pathways are listed in eTable 8.